How can we prevent asthma attacks and improve lives?
Get Involved
Treatment Groups
Treatment Groups
Looking to join the iTREAT Asthma study? Please check back soon for details.
Current Updates
Treatment Groups
Current Updates
Full study is funded! See what we've been up to.
iTREAT Overview
What is iTREAT?
What are the study arms
Who can participate?
The iTREAT asthma study will compare different asthma treatments: a pill or adding a second inhaler to see if they reduce the need for emergency care or going to the hospital.
Every patient will be given online asthma symptom tracking tools that have been shown to help manage asthma symptoms. Some participants will use a second inhaled medicine with their regular rescue or quick relief medicine. Some will start taking an antibiotic pill. Some will use both. The groups are assigned by chance, like a flip of a coin.
Who can participate?
What are the study arms
Who can participate?
Adults or adolescents with asthma cared for at a participating site:
- Atrium Health
- Kelsey
- Mount Sinai
- Reliant
- RWJ-Rutgers
- University of Colorado
- University of North Carolina
- University of Washington
- practices affiliated with the DARTNet Institute and AAFP National Research Network
What are the study arms
What are the study arms
What are the study arms
The study will be a four-arm study with 3,200 people. Study arms will be rescue ICS (use of inhaled corticosteroids as part of rescue therapy), azithromycin therapy, rescue ICS plus azithromycin, or control.
All participants will record their asthma symptoms using online tools.
The primary outcome will be yearly asthma exacerbation rates compared across the three intervention arms to the control arm. Secondary outcomes will be asthma control and asthma quality of life.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.